• Home
  • News
We’re proud to be part of one of 12 centers selected as an Antiviral Drug Discovery (AViDD) Center for Pathogens of Pandemic Concern. We look forward to continuing the work we did in collaboration with the labs of Jeff Glenn, Wah Chiu, Ralph Baric, and other colleagues in SARS-CoV-2 to develop Outpatient Antiviral Cocktails against SARS-CoV-2 and other Potential Pandemic RNA Viruses! Read more at the NIH website.

We’re proud to be part of one of 12 centers selected as an Antiviral Drug Discovery (AViDD) Center for Pathogens of Pandemic Concern. We look forward to continuing the work we did in collaboration with the labs of Jeff Glenn, Wah Chiu, Ralph Baric, and other colleagues in SARS-CoV-2 to develop Outpatient Antiviral Cocktails against SARS-CoV-2 and other Potential Pandemic RNA Viruses! Read more at the NIH website.

We’re proud to be part of one of 12 centers selected as an Antiviral Drug Discovery (AViDD) Center for Pathogens of Pandemic Concern. We look forward to continuing the work we did in collaboration with the labs of Jeff Glenn, Wah Chiu, Ralph Baric, and other colleagues in SARS-CoV-2 to developĀ Outpatient Antiviral Cocktails against SARS-CoV-2 and other Potential Pandemic RNA Viruses! Read more at theĀ NIH website.

Leave a comment

Your email address will not be published. Required fields are marked *